ITR will be attending the Festival of Biologics (March 4–5).

We’re looking forward to connecting with biotech and biopharma teams advancing biologics, vaccines, and advanced therapies, and discussing how ITR supports development programs through integrated in vivo, in vitro, and in silico toxicology, including GLP-compliant, BSL-2 capable studies.

If you’ll be attending and would like to explore how we can support your pipeline, connect with Gregg Nyhus!